Noguchi M, Yabushita K, Tajiri K, Fujii H, Miyazaki I
Jpn J Surg. 1987 Mar;17(2):63-71. doi: 10.1007/BF02470643.
A new operative method of extended radical mastectomy enables complete resection of the axillary and internal mammary lymph nodes. In this paper, we present the histological analysis of the internal mammary involvement, and the estimated 5 year survival rate, of 100 patients with breast cancer of Stage I, II or III, who underwent this operation. The incidences of axillary and internal mammary involvements were 41 per cent and 17 per cent, respectively. The metastases in the internal mammary lymph node chain were located from just below the supraclavicular vein to the third intercostal space along the internal mammary vessels. The types of lymphatic invasion observed in the internal mammary chain were lymph node metastases in 88 per cent, metastatic lesion in the lymphoid tissue in 29 per cent and cancer cell emboli in the lymphatic channel in 71 per cent. The overall estimated 5 year survival rate was 90.5 per cent. Where there was internal mammary involvement, the estimated 5 year survival rates for those with no axillary lymph node metastasis, those with fewer than 3 metastatic axillary lymph nodes, and those with more than 4 metastatic axillary lymph nodes were 100 per cent, 80 per cent and 31.2 per cent, respectively. Although the assumption that more aggressive surgical removal of the primary lesion and the regional lymphatic spread gives a higher cure rate has not been proved, this extended radical mastectomy with adjuvant chemoendocrine therapy seems to give a higher 5 year survival rate for patients with internal mammary involvement.
一种新的扩大根治性乳房切除术手术方法能够完整切除腋窝和胸骨旁淋巴结。在本文中,我们呈现了100例接受此手术的Ⅰ、Ⅱ或Ⅲ期乳腺癌患者的胸骨旁受累情况的组织学分析以及预估的5年生存率。腋窝和胸骨旁受累的发生率分别为41%和17%。胸骨旁淋巴结链中的转移灶位于沿胸骨旁血管从锁骨下静脉下方至第三肋间间隙。在胸骨旁链中观察到的淋巴浸润类型为:88%为淋巴结转移,29%为淋巴组织中的转移病变,71%为淋巴管中的癌细胞栓子。总体预估5年生存率为90.5%。存在胸骨旁受累时,无腋窝淋巴结转移、腋窝转移淋巴结少于3个以及腋窝转移淋巴结多于4个的患者的预估5年生存率分别为100%、80%和31.2%。虽然更积极地手术切除原发灶和区域淋巴转移能带来更高治愈率这一假设尚未得到证实,但这种扩大根治性乳房切除术联合辅助化学内分泌治疗似乎能为有胸骨旁受累的患者带来更高的5年生存率。